Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

GSTC

Globestar Therapeutics (PK) (GSTC)

Globestar Therapeutics Corporation (PK)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:USOTC:GSTC
DatumZeitQuelleÜberschriftSymbolFirma
15/02/202417h33Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:GSTCGlobestar Therapeutics Corporation (PK)
19/01/202423h13Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]USOTC:GSTCGlobestar Therapeutics Corporation (PK)
02/01/202422h21Edgar (US Regulatory)Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405USOTC:GSTCGlobestar Therapeutics Corporation (PK)
13/11/202318h32Edgar (US Regulatory)Form 8-K - Current reportUSOTC:GSTCGlobestar Therapeutics Corporation (PK)
17/08/202322h01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:GSTCGlobestar Therapeutics Corporation (PK)
14/08/202322h31Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:GSTCGlobestar Therapeutics Corporation (PK)
27/06/202323h12Edgar (US Regulatory)Current Report Filing (8-k)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
31/05/202312h03Edgar (US Regulatory)Quarterly Report (10-q)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
15/05/202322h16Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
03/05/202319h35Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
03/05/202319h30Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
06/04/202322h02Edgar (US Regulatory)Current Report Filing (8-k)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
13/02/202323h17Edgar (US Regulatory)Quarterly Report (10-q)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
09/01/202319h48Edgar (US Regulatory)Annual Report (10-k)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
29/12/202222h37Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
22/08/202223h31Edgar (US Regulatory)Quarterly Report (10-q)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
15/08/202222h29Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
16/05/202222h55Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
12/10/202114h28Edgar (US Regulatory)Current Report Filing (8-k)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
04/10/202114h49Edgar (US Regulatory)Current Report Filing (8-k)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
20/09/202114h17Edgar (US Regulatory)Current Report Filing (8-k)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
16/11/201823h30Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
16/11/201823h25Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
16/11/201823h04Edgar (US Regulatory)Current Report Filing (8-k)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
14/11/201816h50Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
14/11/201816h40Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
14/11/201816h38Edgar (US Regulatory)Current Report Filing (8-k)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
14/11/201815h44Edgar (US Regulatory)Quarterly Report (10-q)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
08/11/201822h37Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
07/11/201822h28Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
 Showing the most relevant articles for your search:USOTC:GSTC